. 2023 Aug 25;39(3):414–425. doi: 10.1093/ndt/gfad183
© The Author(s) 2023. Published by Oxford University Press on behalf of the ERA.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Figure 1:
Effect of SGLT2is and ETA receptor antagonists in combination.